Use of biologic agents in idiopathic inflammatory myopathies in Sweden: a descriptive study of real life treatment. [electronic resource]
Producer: 20170824Description: 512-515 p. digitalISSN:- 0392-856X
- Adolescent
- Aged
- Anti-Inflammatory Agents -- adverse effects
- Biological Products -- adverse effects
- Drug Substitution
- Female
- Humans
- Interleukin 1 Receptor Antagonist Protein -- therapeutic use
- Male
- Middle Aged
- Myositis -- diagnosis
- Off-Label Use
- Registries
- Rituximab -- therapeutic use
- Sweden -- epidemiology
- Time Factors
- Treatment Outcome
- Tumor Necrosis Factor-alpha -- antagonists & inhibitors
- Young Adult
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.